Kaplan–Meier curves illustrated increased progression rates among patients with a positive SC ACPA test (>70 AU/mL) in the Karolinska risk RA cohort as well as the TIRx cohort (Fig. 1C + D). This evidence concerns the gene PRTN3 and rheumatoid arthritis.